Introduction:Preeclampsia (PE) is an immensely prevalent condition that poses a significant
risk to both maternal and fetal health. It is recognized as a primary cause of perinatal morbidity
and mortality. Despite extensive research efforts, the precise impact of JDP2 on trophoblast
invasion and migration in the context of preeclampsia remains unclear.Materials and Methods:The present study aimed to investigate the differential expression of JDP2
between normal control and preeclampsia placentas through the use of quantitative polymerase
chain reaction (qPCR), western blotting, and immunostaining techniques. Furthermore, the effects
of JDP2 overexpression and silencing on the migration, invasion, and wound healing capabilities
of HTR-8/SVneo cells were evaluated. In addition, this study also examined the impact of JDP2
on epithelial-mesenchymal transition (EMT)-associated biomarkers and the Wnt/β-catenin pathway.Results:In the present investigation, it was ascertained that Jun dimerization protein 2 (JDP2) exhibited
a substantial decrease in expression levels in placentae afflicted with preeclampsia in comparison
to those of normal placentae. Impairment in migration and invasion was noted upon JDP2
down-regulation, whereas augmentation of migration and invasion was observed upon JDP2 overexpression
in HTR-8/SVneo cells. Subsequently, western blot and immunofluorescence assays
were conducted, revealing marked alterations in EMT-associated biomarkers, such as E-cadherin,
N-cadherin, and β-catenin, thereby indicating that JDP2 can facilitate cell invasion by modulating
the EMT process in HTR-8/SVneo cells. Finally, activation of Wnt/β-catenin signaling was observed
as a result of JDP2. After that, IWR-1, a Wnt inhibitor, was used in the recovery study.
IWR-1 could inhibit the role of JDP2 in promoting migration and invasion in HTR-8/SVneo cells.Conclusion:Our findings elucidated the impact of JDP2 on trophoblast invasion and migration in
preeclampsia by suppressing the EMT through the Wnt/β-catenin signaling pathway, thereby offering
a potential prognostic and therapeutic biomarker for this condition.